Form 4: Ionis Pharmaceuticals Director Reports Stock Transaction
Insider Transaction (Form 4)
Joan E Herman, a Director of Ionis Pharmaceuticals Inc, reported multiple transactions in common stock on July 15, 2026.
Summary
- Option exercise/conversion: acquired 5,220 Common Stock on July 15, 2026; holds 51,306 after (Direct).
- Option exercise/conversion: disposed of 5,220 Restricted Stock Unit on July 15, 2026; holds 2,301 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Joan E Herman — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Option exercise/conversion | Common Stock | 5,220 | — | — | 51,306 |
| 2026-07-15 | Option exercise/conversion | Restricted Stock Unit | 5,220 | — | — | 2,301 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Option exercise/conversion (5,220 shares) |
| 2026-07-15 | Option exercise/conversion (5,220 shares) |
Keywords
insider transaction, Form 4, IONS, IONIS PHARMACEUTICALS INC, neutral, Joan E Herman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.